Psychiatric disorders, sexual trauma associated with LUTS

Article

Depression, anxiety disorders, and sexual trauma appear to be risk factors in lower urinary tract symptoms such as incontinence and overactive bladder, according to a recent study.

Depression, anxiety disorders, and sexual trauma appear to be risk factors in lower urinary tract symptoms such as incontinence and overactive bladder, according to a recent study.

Researchers from the Virginia Commonwealth University School of Medicine and the Hunter Holmes McGuire Veterans Affairs Hospital, Richmond, administered two questionnaires to 121 women referred to a specialized urology clinic for evaluation of LUTS. Data were analyzed according to psychiatric comorbidities, history of sexual trauma, age, race, and obstetric history. Baseline incidence of psychiatric comorbidity and sexual trauma was also compared with a control population of 1,298 women from the Veterans Affairs primary care clinic.

Women referred for evaluation of LUTS had higher rates of psychiatric comorbidities (64.5% vs. 25.9%) and sexual trauma (49.6% vs. 20.1%) compared with those in the primary care clinic. Separate analysis showed that women younger than 50 years and with a history of miscarriage had higher Urogenital Distress Inventory-6 scores, while higher Incontinence Impact Questionnaire-7 scores were associated only with psychiatric comorbidities and history of miscarriage.

"This is the first study to our knowledge to characterize the association of psychiatric comorbidities and sexual trauma with the type, severity, and quality of life impact of LUTS in women using validated surveys," wrote first author Adam P. Klausner, MD, of Virginia Commonwealth. "The prevalence of psychiatric comorbidities and sexual trauma is high in women veterans presenting for evaluation of LUTS."

Study results appeared online in the Journal of Urology (Oct. 21, 2009).

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.